ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002